Table 4 Characteristics of patients with cancer based on the main reasons for the ED visit in 2018. A) Number of ED visits per patient based on the reason for the ED visit B) The distribution of demographic and clinical characteristics of patients with cancer based on the main reasons for the ED visit, C) Number of deaths following last ED presentation
Frequency of ED visits (p = 0.000) | Cancer-related ED visit n = 330 | Oncological care -related ED visit n = 54 | New cancer diagnosis -related ED visit n = 115 | Non-cancer related ED visit n = 913 | Undetermined ED visit n = 100 | Total number of patients with cancer visiting the ED N = 1512 |
1x | 160 (48.5%) | 40 (74.1%) | 102 (88.7%) | 659 (72.2%) | 63 (63.0%) | 1024 (67.7%) |
2-3x | 132 (40.0%) | 14 (25.9%) | 11 (9.6%) | 216 (23.6%) | 33 (33.0%) | 406 (26.8%) |
≥ 4x | 38 (11.5%) | 0 (0.0%) | 2 (1.7%) | 38 (4.2%) | 4 (4.0%) | 82 (5.5%) |
Cancer-related ED visit n = 552 | Oncological care -related ED visit n = 85 | New cancer diagnosis -related ED visit n = 189 | Non-cancer related ED visit n = 1381 | Undetermined ED visit n = 176 | Total number of ED visits by patients with cancer N = 2383 | |
Sex (p = 0.038) | ||||||
Male | 267 (48.4%) | 41 (48.2%) | 110 (58.2%) | 654 (47.4%) | 96 (54.5%) | 1168 (49.0%) |
Female | 285 (51.6%) | 44 (51.8%) | 79 (41.8%) | 727 (52.6%) | 80 (45.5%) | 1215 (51.0%) |
Age (years) (p = 0.000) | ||||||
≤ 65 | 253 (45.8%) | 45 (52.9%) | 78 (41.3%) | 475 (34.4%) | 55 (31.3%) | 906 (38.0%) |
> 65 | 299 (54.2%) | 40 (47.1%) | 111 (58.7%) | 906 (65.6%) | 121 (68.8%) | 1477 (62.0%) |
Admission to ED during business hours (p = 0.311) | ||||||
Yes | 219 (39.7%) | 31 (36.5%) | 88 (46.6%) | 597 (43.2%) | 72 (40.9%) | 1007 (42.3%) |
No | 333 (60.3%) | 54 (63.5%) | 101 (53.4%) | 784 (56.8%) | 104 (59.1%) | 1376 (57.7%) |
Number of comorbidities (p = 0.000) | ||||||
0 | 100 (18.1%) | 17 (20.0%) | 46 (24.3%) | 181 (13.1%) | 25 (14.2%) | 369 (15.5%) |
1 | 130 (23.6%) | 23 (27.1%) | 47 (24.9%) | 279 (20.2%) | 37 (21.0%) | 516 (21.7%) |
≥ 2 | 322 (58.3%) | 45 (52.9%) | 96 (50.8%) | 921 (66.7%) | 114 (64.8%) | 1498 (62.9%) |
Days since previous oncological care (p = 0.000) | ||||||
< 30 days | 165 (35.6%) | 65 (78.3%) | 1 (4.2%) | 146 (12.4%) | 49 (36.8%) | 426 (22.6%) |
≥ 30 days | 299 (64.4%) | 18 (21.7%) | 23 (95.8%) | 1031 (87.6%) | 84 (63.2%) | 1455 (77.4%) |
Triage category (MSTR*) (p = 0.000) | ||||||
5 | 98 (18.2%) | 16 (19.8%) | 65 (34.6%) | 414 (30.8%) | 41 (24.1%) | 634 (27.3%) |
4 | 224 (41.7%) | 46 (56.8%) | 79 (42.0%) | 597 (44.4%) | 82 (48.2%) | 1028 (44.3%) |
3 | 198 (36.9%) | 18 (22.2%) | 41 (21.8%) | 319 (23.7%) | 37 (21.8%) | 613 (26.4%) |
2 | 11 (2.0%) | 1 (1.2%) | 3 (1.6%) | 11 (0.8%) | 4 (2.4%) | 30 (1.3%) |
1 | 6 (1.1%) | 0 (0.0%) | 0 (0.0%) | 5 (0.4%) | 6 (3.5%) | 17 (0.7%) |
Destination from ED (p = 0.000) | ||||||
Discharge | 228 (41.3%) | 39 (45.9%) | 74 (39.2%) | 957 (69.3%) | 86 (48.9%) | 1384 (58.1%) |
Hospitalization | 323 (58.5%) | 45 (52.9%) | 115 (60.8%) | 416 (30.1%) | 84 (47.7%) | 983 (41.3%) |
DAMA** | 1 (0.2%) | 1 (1.2%) | 0 (0.0%) | 8 (0.6%) | 6 (3.4%) | 16 (0.7%) |
Death after last ED visit (p = 0.000) | Cancer-related ED visit n = 330 | Oncological care-related ED visit n = 54 | New cancer diagnosis-related ED visit n = 115 | Non-cancer related ED visit n = 913 | Undetermined ED visit n = 100 | Total number of patients with cancer visiting the ED N = 1512 |
< 30 days | 154 (46.7%) | 9 (16.7%) | 20 (17.4%) | 47 (5.1%) | 22 (22.0%) | 252 (16.7%) |
≥ 30 days | 68 (20.6%) | 8 (14.8%) | 34 (29.6%) | 132 (14.5%) | 23 (23.0%) | 265 (17.5%) |
None | 108 (32.7%) | 37 (68.5%) | 61 (53.0%) | 734 (80.4%) | 55 (55.0%) | 995 (65.8%) |